About the Authors

Eric Pelfrene

eric.pelfrene@ema.europa.eu

Affiliation Office of Anti-infectives and Vaccines, Human Medicines Evaluation Division, European Medicines Agency (EMA), Amsterdam, The Netherlands

Martin Harvey Allchurch

Affiliation International Affairs Division, European Medicines Agency (EMA), Amsterdam, The Netherlands

Nsengi Ntamabyaliro

Affiliation Clinical Pharmacology Unit, University of Kinshasa, Democratic Republic of the Congo

Victoria Nambasa

Affiliation Uganda National Drug Authority, Kampala, Uganda

Fátima V. Ventura

Affiliation Medicines Evaluation Department, National Authority of Medicines and Health Products (INFARMED), Lisbon, Portugal

Nithyanandan Nagercoil

Affiliation Licensing Division, Medicines and Healthcare products Regulatory Agency (MHRA), London, United Kingdom

Marco Cavaleri

Affiliation Office of Anti-infectives and Vaccines, Human Medicines Evaluation Division, European Medicines Agency (EMA), Amsterdam, The Netherlands

Competing Interests

The authors have declared that no competing interests exist.